FIBROMYALGIA
Fibromyalgia is a condition that causes widespread body pain, fatigue, and sensitivity throughout the body. People with fibromyalgia may also have trouble sleeping, concentrating, and carrying out daily activities
The FORWARD Fibromyalgia Study is looking for people who:
• Are at least 18 years of age
• Have fibromyalgia or experience symptoms of fibromyalgia, such as muscle, joint, or bone pain, trouble sleeping, fatigue, or tenderness throughout the body
• Do not have any other conditions that cause pain besides fibromyalgia
• Are interested in participating in the clinical study
*Additional eligibility criteria apply.
About the Study
If you meet the above criteria, the FORWARD Fibromyalgia research study may be of interest to you. This study is looking at how an investigational medication AXS-14, also known as esreboxetine, may help with fibromyalgia pain and other symptoms in adults.
AXS-14 is an investigational medication for fibromyalgia. This means it has not yet been approved by the FDA for use in fibromyalgia. Eligible participants will receive study-related care and evaluations at no cost. Each participant’s fibromyalgia and overall health will be monitored by a team of physicians and study staff. Compensation for your time and travel may be available.
What to Expect
If you are eligible and choose to participate in the FORWARD study, you may be in the study for up to 30 weeks. There are up to 12 in-person visits at the study site and up to 2 remote visits by phone*. As a participant in the study, it is important to understand how many visits you will be attending when you make the decision to participate.
*Some participants may have the opportunity to start a 52-week open-label extension study, where all participants take AXS-14.
​
